GILD Archives - CBOE Blogs

  • Trader Talk | Education | Trade Ideas | Aug 18, 2015, 4:33 AM

    Gilead Sciences Inc. (GILD) Risk, Did Option Market Price It Correctly?

    Gilead Sciences Inc. (GILD) Risk, Did Option Market Price It Correctly?

    Editor’s note:  Park Research LLC @ParkResearch is a relative newcomer to the CBOE Options Hub family.  “Gilead Sciences Inc. (GILD) has 12 products in the Phase II trials and 7 products in the Phase III trials. Everything about the company’s fundamentals can change in a single day when the FDA makes a definitive decision on a late stage drug trial.” (http://www.cmlviz.com/cmld3b/lite.php?app=rc&ticker=GILD) As option traders, we constantly look for[...]

  • Market News | VIX | Blogging Options | Trader Talk | Dec 22, 2014, 11:51 AM

    CBOE Mid-Day Update 12.22.14

    CBOE Mid-Day Update 12.22.14

    Volatility as an asset class Gilead (GILD) option implied volatility has increased after Express Scripts (ESRX) will offer AbbVie's (ABBV) just approved hepatitis C regimen Viekira Pak. Gilead is recently down $15.95 to $92.84.  December weekly put option implied volatility is at 55, January is at 41; compared to its 26-week average of 34. Express Scripts is recently up 93c to $81.91.  January and February call option implied volatility of 19 compared\s to its 26-week average of 20. AbbVie's[...]

  • Market News | Blogging Options | Trader Talk | Dec 22, 2014, 8:09 AM

    Blogging Options: CBOE Morning Update 12.22.14

    Blogging Options: CBOE Morning Update 12.22.14

    Overseas shares higher, US Dollar up against Euro.  GILD off sharply ($12) as AbbVie gets exclusive on a drug.  Lighter volume on Christmas holiday week begins.  Volatility as an asset class The 'Majors' option implied volatilities has spiked as WTI Crude Oil futures trades $57 Exxon Mobil (XOM) overall option implied volatility of 18 compares to its 26-week average of 18. BP (BP) overall option implied volatility of 26 compares to its 26-week average of 18. ConocoPhillips (COP) overall[...]